By contrast, using immunohistochemistry, Schneider et al.12 reported a significantly lower expression of SAMHD1 in 112 AML patients who achieved CR as compared to a group of patients who did not achieve CR. The gene discussed is SAMHD1; the disease is acute myeloid leukemia.